163:
74:
53:
22:
319:
84:
181:
284:
502:
425:
421:
407:
140:
220:
207:
492:
130:
497:
106:
214:
194:
97:
58:
487:
403:
When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.
188:
175:
33:
353:
275:
201:
393:
468:
329:
332:
require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see
424:
to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the
337:
227:
39:
459:
385:
247:
443:
If you have discovered URLs which were erroneously considered dead by the bot, you can report them with
431:
105:
on
Knowledge (XXG). If you would like to participate, please visit the project page, where you can join
384:. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit
325:
21:
347:
428:
before doing mass systematic removals. This message is updated dynamically through the template
444:
333:
240:
233:
89:
451:
356:) has been paid by GCI Health on behalf of Kite Pharma. declared financial relationship
264:
394:
https://web.archive.org/web/20150121074348/http://www.kitepharma.com/c/company/index.php
410:, "External links modified" talk page sections are no longer generated or monitored by
162:
450:
If you found an error with any archives or the URLs themselves, you can fix them with
417:
481:
343:
397:
377:
416:. No special action is required regarding these talk page notices, other than
79:
102:
73:
52:
473:
182:
Knowledge (XXG):Requested articles/Business and economics/Companies
313:
15:
388:
for additional information. I made the following changes:
381:
357:
336:. For advice about reviewing paid contributions, see
101:, a collaborative effort to improve the coverage of
503:
Talk pages of subject pages with paid contributions
420:using the archive tool instructions below. Editors
406:This message was posted before February 2018.
398:http://www.kitepharma.com/c/company/index.php
8:
221:Category:Company articles needing infoboxes
208:Category:Company articles needing attention
376:I have just modified one external link on
170:Here are some tasks awaiting attention:
148:
47:
49:
19:
246:Help expand stub articles located at
115:Knowledge (XXG):WikiProject Companies
7:
195:Category:Unassessed company articles
95:This article is within the scope of
38:It is of interest to the following
14:
380:. Please take a moment to review
317:
272:Tag company talk pages with the
161:
82:
72:
51:
20:
493:Low-importance company articles
135:This article has been rated as
498:WikiProject Companies articles
261:Tag company articles with the
118:Template:WikiProject Companies
1:
109:and see a list of open tasks.
152:WikiProject Companies To-do:
519:
437:(last update: 5 June 2024)
373:Hello fellow Wikipedians,
141:project's importance scale
147:
134:
67:
46:
488:C-Class company articles
474:21:15, 6 May 2017 (UTC)
369:External links modified
248:Category:Company stubs
28:This article is rated
285:requests for comments
276:WikiProject Companies
98:WikiProject Companies
32:on Knowledge (XXG)'s
418:regular verification
326:Wikimedia Foundation
408:After February 2018
462:InternetArchiveBot
413:InternetArchiveBot
34:content assessment
438:
366:
365:
312:
311:
308:
307:
304:
303:
300:
299:
296:
295:
510:
472:
463:
436:
435:
414:
321:
320:
314:
279:
268:
234:Portal:Companies
176:Article requests
165:
158:
157:
149:
123:
122:
121:company articles
119:
116:
113:
92:
90:Companies portal
87:
86:
85:
76:
69:
68:
63:
55:
48:
31:
25:
24:
16:
518:
517:
513:
512:
511:
509:
508:
507:
478:
477:
466:
461:
429:
422:have permission
412:
386:this simple FaQ
371:
318:
292:
289:
273:
262:
120:
117:
114:
111:
110:
88:
83:
81:
61:
29:
12:
11:
5:
516:
514:
506:
505:
500:
495:
490:
480:
479:
456:
455:
448:
401:
400:
392:Added archive
370:
367:
364:
363:
362:
361:
338:WP:COIRESPONSE
322:
310:
309:
306:
305:
302:
301:
298:
297:
294:
293:
291:
290:
288:
287:
281:
280:project banner
270:
258:
250:
236:
223:
210:
197:
184:
169:
167:
166:
154:
153:
145:
144:
137:Low-importance
133:
127:
126:
124:
107:the discussion
94:
93:
77:
65:
64:
62:Low‑importance
56:
44:
43:
37:
26:
13:
10:
9:
6:
4:
3:
2:
515:
504:
501:
499:
496:
494:
491:
489:
486:
485:
483:
476:
475:
470:
465:
464:
453:
449:
446:
442:
441:
440:
433:
427:
423:
419:
415:
409:
404:
399:
395:
391:
390:
389:
387:
383:
379:
374:
368:
359:
355:
352:
349:
345:
342:
341:
339:
335:
331:
327:
323:
316:
315:
286:
282:
277:
271:
266:
260:
259:
257:
255:
251:
249:
245:
243:
242:
237:
235:
232:
230:
229:
224:
222:
219:
217:
216:
211:
209:
206:
204:
203:
198:
196:
193:
191:
190:
185:
183:
180:
178:
177:
172:
171:
168:
164:
160:
159:
156:
155:
151:
150:
146:
142:
138:
132:
129:
128:
125:
108:
104:
100:
99:
91:
80:
78:
75:
71:
70:
66:
60:
57:
54:
50:
45:
41:
35:
27:
23:
18:
17:
460:
457:
432:source check
411:
405:
402:
375:
372:
350:
330:Terms of Use
267:|Companies}}
253:
252:
239:
238:
226:
225:
213:
212:
200:
199:
187:
186:
174:
173:
136:
96:
40:WikiProjects
378:Kite Pharma
482:Categories
469:Report bug
452:this tool
445:this tool
112:Companies
103:companies
59:Companies
458:Cheers.—
354:contribs
344:Vtamgcih
269:template
228:Maintain
202:Copyedit
382:my edit
334:WP:PAID
283:Answer
215:Infobox
139:on the
30:C-class
265:portal
189:Assess
36:scale.
254:Other
241:Stubs
358:here
348:talk
324:The
426:RfC
396:to
340:.
328:'s
131:Low
484::
439:.
434:}}
430:{{
278:}}
274:{{
263:{{
471:)
467:(
454:.
447:.
360:.
351:·
346:(
256::
244::
231::
218::
205::
192::
179::
143:.
42::
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
